DGFT told to curb export of 12 drug ingredients
New Delhi, February 19
The Department of Pharmaceuticals has asked the Directorate General of Foreign Trade (DGFT) to issue orders restricting export of 12 active pharmaceutical ingredients (APIs) and formulations in the wake of the coronavirus outbreak.
A high-level committee formed by the Department of Pharmaceuticals to monitor supply of raw materials for drugs from China has recommended restrictions on export of these items. The 12 APIs and formulations include antibiotics such as choramphenicol,neomycin, metronidazole and vitamins B1, B12, B6 along with progesterone. — PTI
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now
